U.S. Markets close in 4 hrs 11 mins
  • S&P 500

    4,586.34
    +34.66 (+0.76%)
     
  • Dow 30

    35,633.32
    +142.63 (+0.40%)
     
  • Nasdaq

    15,411.70
    +175.87 (+1.15%)
     
  • Russell 2000

    2,284.94
    +32.45 (+1.44%)
     
  • Gold

    1,805.50
    +6.70 (+0.37%)
     
  • EUR/USD

    1.1695
    +0.0088 (+0.7601%)
     
  • 10-Yr Bond

    1.5470
    +0.0180 (+1.18%)
     
  • Vix

    16.44
    -0.54 (-3.18%)
     
  • GBP/USD

    1.3811
    +0.0069 (+0.5000%)
     
  • USD/JPY

    113.3160
    -0.4940 (-0.4341%)
     
  • BTC-USD

    61,281.72
    +2,370.46 (+4.02%)
     
  • CMC Crypto 200

    1,477.37
    +58.00 (+4.09%)
     
  • FTSE 100

    7,240.42
    -12.85 (-0.18%)
     
  • Nikkei 225

    28,820.09
    -278.11 (-0.96%)
     

Core Labs' (CLB) Q2 Earnings and Revenues Miss Estimates

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Core Laboratories N.V. CLB recently reported second-quarter 2021 results wherein adjusted earnings of 18 cents a share missed the Zacks Consensus Estimate of 19 cents. This underperformance is attributable to lower-than-expected revenues from the reservoir description segment. However, the bottom line improved from the year-ago quarter’s earnings of 14 cents per share. This upside was attributable to the year-over-year increase in revenues of the production-enhancement segment and lower year-over-year operating expenses, which declined to $105.9 million from $118.3 million a year ago.

This oilfield service provider’s adjusted revenues of $118.75 million missed the Zacks Consensus Estimate by 0.09%. However, the top line rose from the year-ago quarter’s revenues of $115.74 million.

Segmental Performance

Reservoir Description: Revenues decreased 11.5% to $78.3 million from $88.4 million in second-quarter 2020 and also lagged the Zacks Consensus Estimate of $82 million, thanks to project delays related to the coronavirus pandemic. Moreover, operating income fell from $13.53 million in the year-ago period to $7.27 million and also missed the Zacks Consensus Estimate of $11.50 million. The segment's operating income decreased as the company worked to restore temporary cost-cutting initiatives that had been implemented before. The operating margin of 9.6% was lower than the prior-year quarter’s 17%.

Production Enhancement: Revenues were $40.5 million, comparing favorably with $27.3 million a year earlier and also surpassed the Zacks Consensus Estimate of $36.9 million. Moreover, segmental operating income of $3.83 million in the quarter outpaced the Zacks Consensus Estimate of $3.1 million owing to increased sales and market penetration of unique energetic products and diagnostic services in both U.S. and foreign markets. The year-ago period, however, reported an operating loss of $16.3 million.

Core Laboratories N.V. Price, Consensus and EPS Surprise

Core Laboratories N.V. Price, Consensus and EPS Surprise
Core Laboratories N.V. Price, Consensus and EPS Surprise

Core Laboratories N.V. price-consensus-eps-surprise-chart | Core Laboratories N.V. Quote

Financials and Dividend

As of June 30, 2021, Core Labs had cash and cash equivalents worth $33.6 million and a long-term debt (including lease obligations) of $208.3 million. The company’s debt-to-capitalization was 57.4%.

In the reported quarter, Core Labs generated $9.5 million in operating cash and its capital expenditure totaled $2.9 million. This, in turn, led to a $6.6-million free cash flow (FCF) generation. This is the 79th consecutive quarter of the company’s FCF recognition.

Core Labs’ board of directors approved a regular quarterly dividend of a cent per share on the company's common stock, payable Aug 24, 2021 to all its shareholders of record as of Aug 9, 2021.

2021 View

As the momentum for international crude-oil markets steadily rises and U.S. activity continues to gradually progress, Core Labs remains confident about its growth possibilities for the remainder of 2021.

For the third quarter, Core Labs’ revenues are anticipated in the $122-$126 million range while operating income is estimated in the $14-$15 million band.

As Core Labs’ prospects are directly associated with expanding its client activity and new market penetration, mainly globally, it continues focus on primarily the ongoing development of new client-driven technologies and geographical exploration along with a deepened concentration on digitization and automation throughout its business.

Performance of Other Energy Players

Among other players in the oilfield services industry that already reported second-quarter earnings, the bottom-line results of Schlumberger SLB and Halliburton HAL beat the respective Zacks Consensus Estimate by 15.4% and 18.2%.

Zacks Rank & Key Pick

Core Labs currently carries a Zacks Rank #3 (Hold). Investors interested in the oilfield services space could look at a better-ranked option like Nine Energy Service, Inc. NINE with a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Schlumberger Limited (SLB) : Free Stock Analysis Report

Halliburton Company (HAL) : Free Stock Analysis Report

Core Laboratories N.V. (CLB) : Free Stock Analysis Report

Nine Energy Service, Inc. (NINE) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research